Printer Friendly

PAREXEL APPOINTS FDA OFFICIAL TO SENIOR BIOTECHNOLOGY POST

 WALTHAM, Mass., May 4 /PRNewswire/ -- PAREXEL International Corporation today announced the appointment of A. Seth Pauker, D. Env., M.P.H., to the position of senior director, biotechnology, regulatory affairs division.
 In this newly created position, Dr. Pauker will provide expert scientific and regulatory consulting in biotechnology, including emerging domestic and international policies, regulations and guidelines as they impact on PAREXEL's existing and new client companies.
 Dr. Pauker joins PAREXEL from the U.S. Food and Drug Administration's (FDA) Office of Biotechnology, where he was senior staff member. In this position, Dr. Pauker was principal advisor and consultant to the office director and other senior FDA officials on regulatory and scientific issues impacting biotechnology policies of FDA and, indirectly, of other regulatory bodies around the world.
 Before his tenure at the FDA, Dr. Pauker held several regulatory positions within pharmaceutical and biotechnology companies, including Ortho Pharmaceutical Corporation, where he was director of regulatory affairs. At Biogen Research Corporation, Dr. Pauker was associate director of regulatory affairs. At both Ortho and Biogen, Dr. Pauker played a strategic role in the maturation of their biotechnology product development capabilities.
 "As the efforts of the biotechnology industry turn increasingly toward clinical development and product registration, we recognize the importance of providing the regulatory and scientific expertise to meet these emerging needs," said Dr. Alberto Grignolo, vice president of PAREXEL's regulatory affairs division. "Dr. Pauker's domestic and international expertise is ideally suited to answer these needs, not only because of his ten years of experience in the biotechnology and regulatory affairs professions, but because he helped shape the regulatory environment facing today's biotechnology industry."
 Dr. Pauker earned his doctorate of environmental science and engineering, and his masters in public health in environmental health sciences, from the University of California, Los Angeles.
 PAREXEL International Corporation, an independent pharmaceutical research organization (IPRO), is a leading international provider of clinical research and development services to the pharmaceutical, biotechnology and medical device industries. Headquartered in Waltham, PAREXEL offers a wide range of global services for the planning and implementation of clinical product development programs (Phases I through IV) for the registration of new drugs and other health care products.
 -0- 5/4/93
 /CONTACT: Josef von Rickenbach, chairman and CEO of PAREXEL, 617-487-9900; or Anthony J. Russo, Ph.D., or Susan Noonan of Noonan/Russo Communications, 212-979-9180, for PAREXEL/


CO: PAREXEL International Corporation ST: Massachusetts IN: MTC SU: PER

GK-SH -- NY033 -- 4259 05/04/93 11:11 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 4, 1993
Words:409
Previous Article:ACC CORP. REPORTS RECORD FIRST QUARTER REVENUE AND EARNINGS
Next Article:U.S. BANKNOTE ANNOUNCES FIRST QUARTER EARNINGS
Topics:


Related Articles
PAREXEL AND SMITHKLINE BEECHAM ANNOUNCE AGREEMENT FOR CLINICAL TRIALS
U.S. DEPARTMENT OF COMMERCE AND ISRAELI MINISTRY OF INDUSTRY AND TRADE SPONSOR CLINICAL TRIALS TRAINING PROGRAM IN TEL AVIV
PAREXEL AGREES TO ACQUIRE SITEBASE CLINICAL SYSTEMS, INC.
PAREXEL Acquires CRO in Israel
PAREXEL Reports First Quarter Results and Agrees to Acquire Kemper-Masterson, Inc.
PAREXEL Announces Information Technology Investments
PAREXEL Completes Acquisition of Kemper-Masterson, Inc.
PAREXEL Consulting Expands Risk Management Expertise, Appoints Former FDA Consumer Safety Officer Raymond T. Oji as Senior Consultant.
PAREXEL Expands Leading Imaging Expertise, Appoints Former FDA Division Director George Mills to Vice President, Medical Imaging Consulting.
PAREXEL Expands Consulting Capabilities With Appointments of Washington-D.C. Based Regulatory and Product Development Experts.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters